Name |
Indication |
Stage |
YKRH00114 |
Thick sputum, expectoration or dyspnea caused by chronic bronchitis, COPD, bronchial asthma and other diseases, and can also be used for postoperative dyspnea and pneumonia complications |
Pre clinical |
YKRH00119 |
Pulmonary Fibrosis |
Pre clinical |
YKRH00054 |
COPD |
Pre clinical |
YKRH00318 |
To reduce the risk of COPD exacerbations in patients with severe COPD with chronic bronchitis and a history of exacerbations |
Pre clinical |
YKRH00052 |
COPD, including chronic bronchitis, emphysema |
Pre clinical |
YKRH00056 |
COPD |
Pre clinical |
YKRH00479 |
Acute lung injury/acute respiratory distress syndrome |
Pre clinical |
YKRH00179 |
Pulmonary hypertension |
Pre clinical |
YKRH00118 |
Chronic bronchitis, pneumonia and other respiratory tract inflammation |
Pre clinical |
YKRH00008 |
Respiratory viral infection |
Pre clinical |
YKRH00277 |
Community-acquired pneumonia caused by Streptococcus pneumoniae |
Pre clinical |
YKRH00115 |
Lower respiratory tract infection |
Pre clinical |
YKRH00098 |
Pulmonary disease associated with infections such as Pseudomonas aeruginosa and Haemophilus |
Pre clinical |
YKRH00099 |
Pulmonary disease with Pseudomonas aeruginosa infection |
Pre clinical |
YKRH00481 |
Pulmonary disease with Pseudomonas aeruginosa infection |
Pre clinical |